Cano Health, Inc. (“Cano Health” or the “Company”) (NYSE: CANO), a leading value-based primary care provider for seniors…
Category: Insights
Orthobiologics Market to Grow by $ 2.02 bn at 7.01% CAGR during 2021-2025 | Evolving Opportunities with Dominant Players including Medtronic Plc and Nuvasive Inc.
The orthobiologics market research report has been added to Technavio’s catalog. The market is anticipated to…
Relmada Therapeutics to Report Second Quarter 2021 Financial Results and Host Conference Call and Webcast on August 10, 2021
Relmada Therapeutics, Inc. (Nasdaq: RLMD), a late-stage biotechnology company addressing diseases of the central nervous system (CNS),…
Customized Premixes Market Size Is Projected to Reach $2.38 Billion By 2028
The global customized premixes market size is expected to reach USD 2.38 billion by 2028. according to a new study conducted…
Plastic Medicine Bottles Market Size 2021 by Product Sales, Revenue, Price, Market Share, Growth Opportunity and Forecast to 2027 Research Report
The global market size of the Plastic Medicine Bottles Market is projected to witness a significant…
Herbalife Nutrition Reports Fourth Straight Quarter of Year-Over-Year Double-Digit Net Sales Growth
Herbalife Nutrition Ltd. (NYSE: HLF) today reported financial results for the second quarter ended June 30,…
Nootropic Mushrooms for Wellness Are on the Rise
Kim Koehler, Privy Peach CBD brand founder, was recently listed as a Forbes top entrepreneurs to watch, and with good reason. Kim Koehler has…
Jacobio Announces First Patient Dosed in Phase I/II Clinical Trial of KRAS G12C Inhibitor for Solid Tumor
Jacobio Pharmaceuticals (1167.HK) today announced the first patient was dosed in a Phase I/II clinical trial…
Daewoong Pharmaceutical Announces Camostat Achieving 50% Faster Recovery Time for Mild COVID-19 Patients Over Age of 50 in Topline Results from Phase 2B Clinical Trial
Improvement of symptoms such as cough and dyspnea in mild patients over age 50 was reported to be…
Lantern Pharma Reports Second Quarter 2021 Financial Results and Operational Highlights
Obtained positive preclinical data in pancreatic cancer showing a significant reduction, averaging 93%, in tumor volume…